Diagnostic assay for anti-von willebrand factor cleaving protease (ADAMTS13) antibodies

Details for Australian Patent Application No. 2004232878 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Scheiflinger, Friedrich; Plaimauer, Barbara; Rieger, Manfred

Agent Cullen & Co

Pub. Number AU-B-2004232878

PCT Pub. Number WO2004/095027

Priority 10/422,052 22.04.03 US

Filing date 1 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 28 May 2009

International Classifications

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

G01N 33/86 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/095027 Priority application(s): WO2004/095027

28 May 2009 Application Accepted

  Published as AU-B-2004232878

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232893-Apparatus for and method of installing a mantle clip and mantle on a lantern

2004232865-Dispensing systems